C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1994
11/17/1994	EP0624644A1 DNA fragment, vector containing the DNA fragment, transformant transformed with the vector and process for producing protein using the vector
11/17/1994	EP0624643A2 Decontamination of nucleic acid amplification reactions
11/17/1994	EP0624641A2 Thermostable nucleic acid polymerase
11/17/1994	EP0624201A1 Method for producing soluble t-receptors by co-transfection, and use of resulting products
11/17/1994	EP0624200A1 New polypeptides having granulocyte colony stimulating activity, preparation thereof and pharmaceutical compositions containing said polypeptides
11/17/1994	EP0624199A1 Methods for producing thrombin
11/17/1994	EP0624198A1 Synthetic peptides for a rubella vaccine
11/17/1994	EP0624197A1 Crystal proteins of bacillus thuringiensis, genes encoding them, and hosts expressing them
11/17/1994	EP0624196A1 Polypeptides with fibronectin binding sites as modulators for matrix assembly.
11/17/1994	EP0624195A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
11/17/1994	EP0624194A1 Polypeptides derived from human aiv apolipoprotein, preparation and use thereof
11/17/1994	EP0624193A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins
11/17/1994	EP0624192A1 Novel protein tyrosine kinases
11/17/1994	EP0624100A1 Dna encoding a human serotonin receptor (5-ht 4b?) and uses thereof
11/17/1994	EP0624059A1 Combinatorial strategies for polymer synthesis
11/17/1994	EP0563280B1 Tissue plasminogen activator substitution variant
11/17/1994	EP0531448B1 Mammalian expression of the bmp-2 family
11/17/1994	EP0513133B1 Expression of a multigene rna with self-splicing activity
11/17/1994	EP0300033B1 Cytotoxic lymphocyte-specific protease-related molecules and methods
11/17/1994	EP0109441B1 Human-human hybridomas for neoplasms
11/16/1994	CN1095106A Vaccines
11/16/1994	CN1095105A Production of D-pantoic acid and D-pantothenic acid
11/16/1994	CN1094965A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
11/15/1994	US5365017 Method and composition for increasing sterol accumulation in higher plants
11/15/1994	US5365016 Plant cell is transformed using gene
11/15/1994	US5365015 Antisense constructs derived from pTOM13 plants and plant cells with reduced ethylene evolution
11/15/1994	US5364934 Plasma carboxypeptidase
11/15/1994	US5364793 Methods for the diagnosis of peripheral nerve damage
11/15/1994	US5364791 Progesterone receptor having C. terminal hormone binding domain truncations
11/15/1994	US5364790 In situ PCR amplification system
11/15/1994	US5364787 Genes and enzymes involved in the microbial degradation of pentachlorophenol
11/15/1994	US5364785 Incubation in serum-free medium
11/15/1994	US5364783 Retrovirus promoter-trap vectors
11/15/1994	US5364782 Mutant microbial α-amylases with increased thermal, acid and/or alkaline stability
11/15/1994	US5364781 Process for preparing daunorubicin
11/15/1994	US5364780 External regulation of gene expression by inducible promoters
11/15/1994	US5364779 Process for transforming cells
11/15/1994	US5364774 Isolation of polynucleotides like DNA, hybridization and degeneration
11/15/1994	US5364773 Vaccinia virus with deletions; safety
11/15/1994	US5364771 Genetic engineering
11/15/1994	US5364770 Bovine chymosin and glucoamylase
11/15/1994	US5364763 Techniques for preparing specimens for bacterial assays
11/15/1994	US5364761 Method for isolating a DNA encoding an autonomously replicating sequence
11/15/1994	US5364760 Replicative RNA reporter systems
11/15/1994	US5364451 Phytoremediation of metals
11/15/1994	CA2123364A1 Process for purification of water soluble penicillin binding protein 2a
11/12/1994	CA2123252A1 Polypeptide and dnas encoding it
11/12/1994	CA2123251A1 Polypeptide and dnas encoding it
11/12/1994	CA2123250A1 Polypeptide and dnas encoding it
11/12/1994	CA2123249A1 Polypeptide and dnas encoding it
11/12/1994	CA2122937A1 Human chondromodulin-i protein
11/10/1994	WO1994025625A1 Means for detecting familial colon cancer (fcc)
11/10/1994	WO1994025617A2 Monoclonal antibodies against ck-mb
11/10/1994	WO1994025616A1 Cell-targeted lytic pore-forming agents
11/10/1994	WO1994025613A1 Isolated dna elements that direct pistil-specific and anther-specific gene expression and methods of using same
11/10/1994	WO1994025612A2 Nucleotide sequences for the control of the expression of dna sequences in a cellular host
11/10/1994	WO1994025611A1 Integrative dna segment comprising gene encoding insecticidal protein
11/10/1994	WO1994025609A1 Method for creating optimized regulatory regions affecting protein expression and protein trafficking
11/10/1994	WO1994025608A1 Natural or recombinant dna binding proteins as carriers for gene transfer or gene therapy
11/10/1994	WO1994025606A2 Recombinant alanine racemase and gapdh from tolypocladium
11/10/1994	WO1994025605A1 Variant aspartokinase gene
11/10/1994	WO1994025604A2 Steroid 21-hydroxylase fragments and assays using the same
11/10/1994	WO1994025603A1 Cholesterol-oxidase from brevibacterium sterolicum
11/10/1994	WO1994025602A1 Hepatitis-c virus type 4, 5 and 6
11/10/1994	WO1994025601A2 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
11/10/1994	WO1994025600A1 Recombinant antigens from mumps virus and their use in vaccines
11/10/1994	WO1994025599A1 Mammal cell lines and method of obtaining glycoproteins
11/10/1994	WO1994025598A2 Methods and compositions for salmonella-based vaccines
11/10/1994	WO1994025597A2 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA)
11/10/1994	WO1994025596A2 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS
11/10/1994	WO1994025595A2 Cytolysin gene and gene product
11/10/1994	WO1994025594A2 Cloning, expression and vaccine composition corresponding to a peptide antigen of toxoplasma gondii
11/10/1994	WO1994025593A2 Method for obtaining male-sterile plants
11/10/1994	WO1994025592A1 A novel gene coding human epidermal growth factor and process for preparing the same
11/10/1994	WO1994025591A1 PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE)
11/10/1994	WO1994025590A2 Trichohyalin and transglutaminase-3 and methods of using same
11/10/1994	WO1994025589A1 Cannabinoid receptor expressed in cells of the immune system
11/10/1994	WO1994025588A2 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β)
11/10/1994	WO1994025586A1 Transgenic animals having an engineered immune response
11/10/1994	WO1994025585A1 Transgenic non-human animals capable of producing heterologous antibodies
11/10/1994	WO1994025583A1 A recombinant trypsin-like protease
11/10/1994	WO1994025582A1 Method of enhancing thrombolysis
11/10/1994	WO1994025578A1 New lipase variants for use in detergent applications
11/10/1994	WO1994025577A1 Lipase variants
11/10/1994	WO1994025576A1 An enzyme exhibiting mannanase activity
11/10/1994	WO1994025575A1 An enzyme exhibiting pectin methylesterase activity
11/10/1994	WO1994025572A1 Mycobacterial species-specific reporter mycobacteriophages
11/10/1994	WO1994025567A1 CLONING AND EXPRESSION OF THE CHONDROITINASE I AND II GENES FROM $i(P. VULGARIS)
11/10/1994	WO1994025565A1 HUMAN $i(SYK)
11/10/1994	WO1994025491A1 Fibrin-targeted inhibitors of thrombin
11/10/1994	WO1994025486A1 Improved hcv diagnostic agents
11/10/1994	WO1994025484A1 Biologically active peptides
11/10/1994	WO1994025477A2 Novel peptide nucleic acids
11/10/1994	WO1994025473A1 Process and device for preparing dna sodium salt
11/10/1994	WO1994025073A1 Recombinant viruses and their use in gene therapy
11/10/1994	WO1994025066A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
11/10/1994	WO1994025060A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
11/10/1994	WO1994025055A1 Erythropoietin analog compositions and methods
11/10/1994	WO1994025037A1 Anti-viral guanosine-rich oligonucleotides
11/10/1994	WO1994025036A1 Expression inhibitor containing antisense oligonucleotide derivative against human interleukin-6 receptor

1 ... 3788 3789 3790 3791 3792 3793 3794 3795 3796 3797 3798 3799 3800 3801 3802 3803 3804 3805 3806 3807 3808 ... 4023